Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hyperthermia, Induced"" wg kryterium: Temat


Tytuł:
Multi-criterion optimization of invasive antenna applicators for Au@Fe 3 O4, Au@-Fe 2 O 3 and Au@-Fe 2 O 3 mediated microwave ablation treatment.
Autorzy:
Singla A; Electronics and Communication Engineering Department, SLIET Longowal, Sangrur, India.
Marwaha A; Electronics and Communication Engineering Department, SLIET Longowal, Sangrur, India.
Marwaha S; Electrical and Instrumentation Engineering Department, SLIET Longowal, Sangrur, India.
Pokaż więcej
Źródło:
Electromagnetic biology and medicine [Electromagn Biol Med] 2023 Jan 02; Vol. 42 (1), pp. 21-40. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperthermia, Induced*
Radiofrequency Ablation*
Humans ; Microwaves/therapeutic use ; Hot Temperature ; Gold
Czasopismo naukowe
Tytuł:
Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study.
Autorzy:
Yang R; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Su YD; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Liu G; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Yu Y; Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Li XB; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhao X; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.
Ji ZH; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Ma R; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Yang ZR; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Lin YL; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wu HL; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.
Li Y; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2182749.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pseudomyxoma Peritonei*/drug therapy
Peritoneal Neoplasms*/surgery
Hyperthermia, Induced*/adverse effects
Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Cytoreduction Surgical Procedures/adverse effects ; Case-Control Studies ; Retrospective Studies ; Treatment Outcome ; Combined Modality Therapy ; Survival Rate
Czasopismo naukowe
Tytuł:
Predictions of optimal heating by magnetic reversal behavior of magnetic nanowires (MNWs) with different materials.
Autorzy:
Chen Y; Department of Chemical Engineering and Material Science, University of Minnesota, Minneapolis, MN, USA.
Stadler BJH; Department of Chemical Engineering and Material Science, University of Minnesota, Minneapolis, MN, USA.; Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2223371.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Nanowires*
Hyperthermia, Induced*
Heating ; Magnetics ; Magnetic Fields
Czasopismo naukowe
Tytuł:
Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
Autorzy:
Yang Y; Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Huangfu L; Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Li H; Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Yang D; Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2270654. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms*/pathology
Hyperthermia, Induced*
Humans ; Carcinogenesis ; Cell Transformation, Neoplastic/metabolism ; Glycolysis ; Hyperthermia ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review.
Autorzy:
Veltsista PD; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Oberacker E; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ademaj A; Kantonsspital Aarau, Centre for Radiation Oncology KSA-KSB, Aarau, Switzerland.; Doctoral Clinical Science Program, University of Zürich, Zürich, Switzerland.
Corradini S; Department of Radiation Oncology, University Hospital Ludwig Maximilians Universität, München, Germany.
Eckert F; Department of Radiation Oncology, Eberhard Karls University Tuebingen, Tübingen, Germany.; Department of Radiation Oncology, Medical University of Vienna/AKH, Vienna, Austria.
Flörcken A; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kaul D; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lindner LH; Department of Medical Oncology, University Hospital Ludwig Maximilians Universität, München, Germany.
Issels R; Department of Medical Oncology, University Hospital Ludwig Maximilians Universität, München, Germany.
Ott OJ; Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.
Pink D; Department of Medical Oncology, Helios Klinikum Bad Saarow, Bad Saarow, Germany.; Clinic for Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany.
Potkrajcic V; Department of Radiation Oncology, Eberhard Karls University Tuebingen, Tübingen, Germany.
Reichardt P; Department of Medical Oncology, Helios Hospital Berlin-Buch, Berlin, Germany.
Roohani S; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Spalek MJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Riesterer O; Kantonsspital Aarau, Centre for Radiation Oncology KSA-KSB, Aarau, Switzerland.
Zips D; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ghadjar P; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2236337.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms:
Hyperthermia, Induced*/methods
Sarcoma*/therapy
Soft Tissue Neoplasms*/drug therapy
Humans ; Combined Modality Therapy ; Ifosfamide/therapeutic use
Czasopismo naukowe
Tytuł:
Application of HIPEC simulations for optimizing treatment delivery strategies.
Autorzy:
Löke DR; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
Kok HP; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
Helderman RFCPA; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The Netherlands.
Bokan B; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The Netherlands.
Franken NAP; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The Netherlands.
Oei AL; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.; Center for Experimental and Molecular Medicine (CEMM), Laboratory for Experimental Oncology and Radiobiology (LEXOR), Amsterdam, The Netherlands.
Tuynman JB; Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Tanis PJ; Department of Surgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Crezee J; Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2218627.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*/methods
Peritoneal Neoplasms*/drug therapy
Peritoneal Neoplasms*/surgery
Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Combined Modality Therapy ; Chemotherapy, Cancer, Regional Perfusion/methods ; Cytoreduction Surgical Procedures/methods
Czasopismo naukowe
Tytuł:
Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
Autorzy:
Su YD; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Zhao X; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.
Ma R; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Fu YB; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Yang ZR; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Wu HL; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.
Yu Y; Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Yang R; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Liang XL; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Du XM; Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Chen Y; Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Li Y; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.; Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Peking University Ninth School of Clinical Medicine, Beijing, China.; Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2223374.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Hyperthermia, Induced*/methods
Mesothelioma*/drug therapy
Mesothelioma*/surgery
Mesothelioma, Malignant*
Peritoneal Neoplasms*/drug therapy
Peritoneal Neoplasms*/surgery
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bayes Theorem ; Combined Modality Therapy ; Cytoreduction Surgical Procedures/methods ; Hyperthermic Intraperitoneal Chemotherapy ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.
Autorzy:
Xia Y; School of Clinical Medical, Weifang Medical University, Weifang, China.; Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, China.
Wang H; Department of Gynecology and Obstetrics, Weifang People's Hospital, Weifang, China.
Zhang J; Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, China.
Wang Y; Department of Gynecology and Obstetrics, Beijing Jishuitan Hospital, Beijing, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2165729.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*/methods
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/surgery
Humans ; Female ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Prognosis ; Hyperthermic Intraperitoneal Chemotherapy ; Cytoreduction Surgical Procedures/methods ; Platinum/therapeutic use ; Combined Modality Therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Autorzy:
Willner A; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.; Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Agaimy A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Fechner K; Department of Haematology and Oncology, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Ott O; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Denz A; Department of Haematology and Oncology, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Weissmann T; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Meidenbauer N; Department of Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Höfler D; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Gaipl U; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Frey B; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Schmidt M; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Haller F; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Horch R; Department of Hand- and Plastic Surgery, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Grützmann R; Department of Haematology and Oncology, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Semrau S; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2248424.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcoma*/therapy
Soft Tissue Neoplasms*/therapy
Hyperthermia, Induced*
Humans ; Neoadjuvant Therapy ; Ifosfamide ; Retrospective Studies ; Hyperthermia ; Chemoradiotherapy ; Doxorubicin/therapeutic use
Czasopismo naukowe
Tytuł:
Influence of fecal microbial transplant (FMT) between male and female rats on methamphetamine-induced hyperthermia.
Autorzy:
Aburahma A; The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH, USA.
Stewart EL; The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH, USA.
Rana S; The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, USA.
Larsen R; The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, USA.
Ward CS; The Department of Biological Sciences, Bowling Green State University, Bowling Green, OH, USA.
Sprague JE; The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH, USA.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2159072.
Typ publikacji:
Journal Article
MeSH Terms:
Methamphetamine*
Clostridium Infections*/microbiology
Clostridium Infections*/therapy
Hyperthermia, Induced*
Male ; Female ; Rats ; Animals ; Feces/microbiology ; RNA, Ribosomal, 16S/genetics ; Bacteria
Czasopismo naukowe
Tytuł:
Using MRI to measure position and anatomy changes and assess their impact on the accuracy of hyperthermia treatment planning for cervical cancer.
Autorzy:
VilasBoas-Ribeiro I; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Franckena M; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
van Rhoon GC; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Applied Radiation and Isotopes, Reactor Institute Delft, Delft University of Technology, Delft, The Netherlands.
Hernández-Tamames JA; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Paulides MM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Care and Cure research lab (EM-4C&C) of the Electromagnetics Group, Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2151648.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*/methods
Uterine Cervical Neoplasms*
Therapy, Computer-Assisted*/methods
Female ; Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
Autorzy:
Brummelhuis ISG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Crezee J; Department of Radiotherapy, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2157498.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperthermia, Induced*/methods
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Humans ; Mitomycin/therapeutic use ; Epirubicin/therapeutic use ; Combined Modality Therapy ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/drug therapy
Czasopismo naukowe
Tytuł:
Publications on ultrasound-guided thermal ablation for thyroid nodules from 2000 to 2022: a bibliometric analysis.
Autorzy:
Tang J; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.
Wang L; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.; Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing, China.
Sun Z; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.
Liu X; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.; Capital Medical University, Beijing, China.
Li H; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.
Ma J; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.
Xi X; Department of Ultrasound, China-Japan Friendship Hospital, China Beijing.
Zhang B; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Ultrasound, China-Japan Friendship Hospital, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine of Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2268874. Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Thyroid Nodule*/diagnostic imaging
Thyroid Nodule*/surgery
Hyperthermia, Induced*
Humans ; Neoplasm Recurrence, Local ; Bibliometrics ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł:
Fever-range whole body hyperthermia leads to changes in immune-related genes and miRNA machinery in Wistar rats.
Autorzy:
Kozłowski HM; Department of Immunology, Faculty of Veterinary and Biological Sciences, Nicolaus Copernicus University, Torun, Poland.; Department of Genetics, Faculty of Biological Sciences, Kazimierz Wielki University, Bydgoszcz, Poland.
Sobocińska J; Department of Immunology, Faculty of Veterinary and Biological Sciences, Nicolaus Copernicus University, Torun, Poland.
Jędrzejewski T; Department of Immunology, Faculty of Veterinary and Biological Sciences, Nicolaus Copernicus University, Torun, Poland.
Maciejewski B; Department of Immunology, Faculty of Veterinary and Biological Sciences, Nicolaus Copernicus University, Torun, Poland.
Dzialuk A; Department of Genetics, Faculty of Biological Sciences, Kazimierz Wielki University, Bydgoszcz, Poland.
Wrotek S; Department of Immunology, Faculty of Veterinary and Biological Sciences, Nicolaus Copernicus University, Torun, Poland.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2216899.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
Hyperthermia, Induced*
Rats ; Animals ; Rats, Wistar ; Interleukin-10 ; Leukocytes, Mononuclear ; Cytokines ; Granulocyte Colony-Stimulating Factor
Czasopismo naukowe
Tytuł:
Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis.
Autorzy:
Yang H; Department of Internal Medicine, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Li M; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Liu T; Chongqing Bishan Hospital of Traditional Chinese Medicine, Chongqing, China.
Luo L; Department of Internal Medicine, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2225817.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/pathology
Hyperthermia, Induced*
Carcinoid Tumor*/surgery
Carcinoid Tumor*/pathology
Carcinoma, Neuroendocrine*/pathology
Humans ; Treatment Outcome ; Proportional Hazards Models ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Clinical wIRA-hyperthermia: heating properties and effectiveness in lower trunk regions and its accordance with ESHO quality criteria for superficial hyperthermia.
Autorzy:
Piazena H; Interdisciplinary Center of Sleep Medicine, Charité - University Medicine Berlin, Berlin, Germany.
Vaupel P; Department of Radiation Oncology, University Medical Center, University of Freiburg, Freiburg/Brsg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomsen AR; Department of Radiation Oncology, University Medical Center, University of Freiburg, Freiburg/Brsg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2244208.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*
Abdominal Wall*
Humans ; Heating ; Hyperthermia
Czasopismo naukowe
Tytuł:
Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy.
Autorzy:
Jing L; Department of Urology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Wenjian C; Department of Urology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Meimei Z; Department of Pharmacy, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Yanfei C; Department of Urology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Xuejin Z; Department of Urology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Bin W; Department of Urology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2129103.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*/adverse effects
Urinary Bladder Neoplasms*/drug therapy
Humans ; Gemcitabine ; Incidence ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Pilot Projects
Czasopismo naukowe
Tytuł:
Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle-invasive bladder cancer: quality analysis of hyperthermia and impact on clinical results.
Autorzy:
Ademaj A; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.; Doctoral Clinical Science Program, Medical Faculty, University of Zürich, Zürich, Switzerland.
Puric E; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Marder D; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Timm O; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Kern T; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Hälg RA; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.; Institute of Physics, Science Faculty, University of Zürich, Zürich, Switzerland.
Rogers S; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Riesterer O; Centre for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2275540. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hyperthermia, Induced*/methods
Urinary Bladder Neoplasms*/therapy
Humans ; Aged ; Aged, 80 and over ; Reproducibility of Results ; Frail Elderly ; Combined Modality Therapy ; Muscles
Czasopismo naukowe
Tytuł:
Mild magnetic hyperthermia is synergistic with an antibiotic treatment against dual species biofilms consisting of S. aureus and P. aeruginosa by enhancing metabolic activity.
Autorzy:
Almutairi LA; School of Biomedical Sciences, Kent State University, Kent, OH, USA.; Department of Biology, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Yu B; Department of Biological Sciences, Kent State University, Kent, OH, USA.
Dyne E; School of Biomedical Sciences, Kent State University, Kent, OH, USA.
Ojaym AA; School of Biomedical Sciences, Kent State University, Kent, OH, USA.
Kim MH; School of Biomedical Sciences, Kent State University, Kent, OH, USA.; Department of Biological Sciences, Kent State University, Kent, OH, USA.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2226845.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*
Diabetes Mellitus, Experimental*
Hyperthermia, Induced*
Mice ; Animals ; Staphylococcus aureus ; Pseudomonas aeruginosa ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Biofilms ; Ciprofloxacin/pharmacology ; Ciprofloxacin/therapeutic use ; Magnetic Phenomena
Czasopismo naukowe
Tytuł:
Broadband microwave spiral applicator (105-125 MHz) for in vitro examinations of hyperthermia-induced tumor cell death forms - first analyses with human breast cancer cells.
Autorzy:
Walter J; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Hader M; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Sengedorj A; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Frey B; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Gaipl US; Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2023; Vol. 40 (1), pp. 2265590. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/therapy
Hyperthermia, Induced*/methods
Humans ; Female ; Microwaves/therapeutic use ; Hot Temperature ; Hyperthermia ; Apoptosis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies